Applied Therapeutics, Inc. (APLT)
NASDAQ: APLT · Real-Time Price · USD
9.21
-0.22 (-2.33%)
Nov 21, 2024, 10:43 AM EST - Market open
Applied Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
Nov '24 Nov 21, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Market Capitalization | 1,072 | 259 | 37 | 235 | 495 | 505 | |
Market Cap Growth | 521.07% | 608.33% | -84.43% | -52.60% | -2.00% | - | |
Enterprise Value | 1,000 | 223 | -8 | 129 | 382 | 472 | |
Last Close Price | 9.43 | 3.35 | 0.76 | 8.95 | 22.01 | 27.28 | |
PS Ratio | -4604.69 | 25.89 | - | - | - | - | |
PB Ratio | 186.23 | -15.09 | 8.99 | 3.75 | 6.04 | 15.49 | |
P/TBV Ratio | 165.68 | - | 8.99 | 3.75 | 6.04 | 15.49 | |
EV/Sales Ratio | - | 22.27 | - | - | - | - | |
Debt / Equity Ratio | 0.33 | -0.05 | 0.37 | 0.03 | 0.03 | 0.06 | |
Asset Turnover | - | 0.21 | - | - | - | - | |
Quick Ratio | 1.00 | 0.70 | 0.92 | 3.07 | 4.58 | 2.76 | |
Current Ratio | 1.06 | 0.76 | 1.12 | 3.34 | 4.83 | 3.27 | |
Return on Equity (ROE) | - | - | -247.77% | -146.16% | -164.06% | -187.97% | |
Return on Assets (ROA) | -76.01% | -86.56% | -80.84% | -67.91% | -77.23% | -83.02% | |
Return on Capital (ROIC) | - | - | -147.63% | -88.36% | -98.90% | -112.91% | |
Earnings Yield | -17.07% | -46.29% | -225.90% | -45.00% | -18.98% | -9.01% | |
FCF Yield | -7.46% | -21.33% | -213.81% | -38.67% | -15.80% | -7.19% | |
Buyback Yield / Dilution | -89.66% | -122.72% | -47.77% | -16.53% | -71.19% | -134.01% | |
Total Shareholder Return | -89.66% | -122.72% | -47.77% | -16.53% | -71.19% | -134.01% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.